- Published on
Ophthalmology – Cavernous Hemangioma of the Retina
Cavernous hemangioma of the retina is a rare, congenital vascular hamartoma characterized by clusters of dilated, thin-walled vascular sacs within the retina. These lesions are typically benign and nonprogressive, and many patients remain asymptomatic throughout life. Because of its rarity and often silent presentation, the true incidence and prevalence are difficult to determine.
This condition may occur sporadically or as part of an inherited syndrome. Familial cases follow an autosomal dominant pattern and are associated with neuro-oculo-cutaneous syndromes, including familial cerebral cavernous malformations (CCM). These syndromes involve vascular malformations in the retina, central nervous system, and skin. Genetic loci associated with familial cases include CCM1 (7q21–q22), CCM2 (7p15–p13), and CCM3 (3q25.2–q27). Patients with systemic involvement may experience neurological symptoms such as seizures, headaches, or intracranial hemorrhage.
Clinically, patients may present with decreased vision or floaters, although most are asymptomatic and diagnosed incidentally during routine examination. On fundoscopic examination, the lesion appears as a classic “grape-like” cluster of dark red saccular aneurysms arising from the inner retina or optic nerve surface. These vascular sacs contain slow-moving venous blood and are often associated with overlying gliosis or fibrosis. Unlike other retinal vascular tumors, there are typically no prominent feeding or draining vessels.
Fluorescein angiography is highly useful in confirming the diagnosis. It demonstrates delayed filling of the vascular sacs and a characteristic “plasma–erythrocyte layering” effect, where lighter plasma separates from darker red blood cells within the saccules. Importantly, there is usually no leakage of dye, which helps distinguish this condition from other vascular lesions. Because of the potential association with central nervous system lesions, MRI of the brain is recommended to evaluate for cerebral cavernous malformations.
The differential diagnosis includes retinal vascular conditions such as Coats disease (retinal telangiectasia), retinal hemangioblastoma, and racemose angioma. These conditions differ in their vascular patterns, leakage characteristics, and systemic associations.
In most cases, no treatment is required, as the condition is stable and rarely affects vision. Intervention is reserved for complications such as vitreous hemorrhage or significant visual impairment. In such cases, options may include laser photocoagulation or vitrectomy.
Ongoing care involves regular ophthalmologic follow-up and evaluation for systemic involvement. Patients may also require neurologic and dermatologic assessment, especially if a familial syndrome is suspected. Screening of first-degree relatives is recommended in familial cases.
The prognosis is generally excellent. Visual loss is uncommon, and lesions often remain stable or may even undergo spontaneous thrombosis. However, complications can occur, including vitreous hemorrhage, epiretinal membrane formation, and, in systemic cases, intracranial hemorrhage. Early recognition and appropriate systemic evaluation are important for comprehensive patient care.
Cavernous hemangioma of the retina is a rare, congenital vascular hamartoma characterized by clusters of dilated, thin-walled vascular sacs within the retina. These lesions are typically benign and nonprogressive, and many patients remain asymptomatic throughout life. Because of its rarity and often silent presentation, the true incidence and prevalence are difficult to determine.
This condition may occur sporadically or as part of an inherited syndrome. Familial cases follow an autosomal dominant pattern and are associated with neuro-oculo-cutaneous syndromes, including familial cerebral cavernous malformations (CCM). These syndromes involve vascular malformations in the retina, central nervous system, and skin. Genetic loci associated with familial cases include CCM1 (7q21–q22), CCM2 (7p15–p13), and CCM3 (3q25.2–q27). Patients with systemic involvement may experience neurological symptoms such as seizures, headaches, or intracranial hemorrhage.
Clinically, patients may present with decreased vision or floaters, although most are asymptomatic and diagnosed incidentally during routine examination. On fundoscopic examination, the lesion appears as a classic “grape-like” cluster of dark red saccular aneurysms arising from the inner retina or optic nerve surface. These vascular sacs contain slow-moving venous blood and are often associated with overlying gliosis or fibrosis. Unlike other retinal vascular tumors, there are typically no prominent feeding or draining vessels.
Fluorescein angiography is highly useful in confirming the diagnosis. It demonstrates delayed filling of the vascular sacs and a characteristic “plasma–erythrocyte layering” effect, where lighter plasma separates from darker red blood cells within the saccules. Importantly, there is usually no leakage of dye, which helps distinguish this condition from other vascular lesions. Because of the potential association with central nervous system lesions, MRI of the brain is recommended to evaluate for cerebral cavernous malformations.
The differential diagnosis includes retinal vascular conditions such as Coats disease (retinal telangiectasia), retinal hemangioblastoma, and racemose angioma. These conditions differ in their vascular patterns, leakage characteristics, and systemic associations.
In most cases, no treatment is required, as the condition is stable and rarely affects vision. Intervention is reserved for complications such as vitreous hemorrhage or significant visual impairment. In such cases, options may include laser photocoagulation or vitrectomy.
Ongoing care involves regular ophthalmologic follow-up and evaluation for systemic involvement. Patients may also require neurologic and dermatologic assessment, especially if a familial syndrome is suspected. Screening of first-degree relatives is recommended in familial cases.
The prognosis is generally excellent. Visual loss is uncommon, and lesions often remain stable or may even undergo spontaneous thrombosis. However, complications can occur, including vitreous hemorrhage, epiretinal membrane formation, and, in systemic cases, intracranial hemorrhage. Early recognition and appropriate systemic evaluation are important for comprehensive patient care.
0 Comments
